glp-1 molecular structure Glucagon-like Peptide 1 (9-36) - Amide GLP-1R agonist 13 | GLP-1

It shares 94% structural homology with human GLP-1, meaning the vast majority of its amino acid sequence is identical to the hormone your body already produces

Combination therapy Patients with type 2 diabetes mellitus to improve glycemic control in combination with sulfonylurea derivatives (triple combination: metformin + sitagliptin + sulfonylurea derivative) when diet and exercise regimen in combination with two of these three drugs (metformin, sitagliptin or sulfonylurea derivatives) are not lead to adequate glycemic control

Common terminology criteria for adverse events

it is not stable at dilute working concentrations in aqueous solution